Conformational disease

Lancet

Volumn 350, Issue 9071, 1997, Pages 134-138

  Carrell, Robin W ^a   Lomas, David A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PROTEIN; PRION PROTEIN; PROTEIN; SERINE PROTEINASE INHIBITOR;

ALZHEIMER DISEASE; AMYLOIDOSIS; BRAIN DISEASE; CONFORMATIONAL TRANSITION; DEGENERATIVE DISEASE; DEMENTIA; HUMAN; HUNTINGTON CHOREA; ONSET AGE; PRIORITY JOURNAL; PROTEIN FOLDING; SHORT SURVEY; STRESS; SUDDEN INFANT DEATH SYNDROME;

EID: 0030841343     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)02073-4     Document Type: Review

References (40)

1. Bayreuther K, Masters CL. Alzheimer's disease. Tangle disentanglement. Nature 1996; 383: 476-77.
2. Collinge J, Rosser M. A new variant of prion disease. Lancet 1996; 347: 916-17.
3. Collee JG. A dreadful challenge. Lancet 1996; 347: 917-18.
4. Prusiner SB. Prion diseases of humans and animals. J Roy Coll Phys 1994; 28: 1-30.
5. Rick R, Horneman S, Wider G, Billeter M, Glockshuber R, Wüthrick K. NMR structure of the mouse prion protein domain PrPC (121-231). Nature 1996; 382: 180-82.
6. Huang Z, Prusiner SB, Cohen FE. Scrapie prions: a three-dimensional model of an infectious fragment. Folding Design 1996; 1: 13-19.
7. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347: 921-25.
8. Stein PE, Carrell RW. What do dysfunctional serpins tell us about molecular mobility and disease? Nat Struct Biol 1995; 2: 96-113.
9. Carrell RW, Stein PE. The biostructural pathology of the serpins: critical function of sheet opening mechanism. Biol Chem Hoppe-Seyler 1996; 377: 1-17.
10. 1-antitrypsin deficiency. Scand J Clin Lab Invest 1963; 15: 132-40.
11. 1-antitrypsin deficiency. Q J Med 1996; 89: 807-12.
12. 1-antitrypsin accumulation in the liver. Nature 1992; 357: 605-07.
13. 1-antitrypsin. Nat Struct Biol 1996; 3: 676-81.
14. 1-antitrypsin deficiency in early childhood. Pediatrics 1978; 62: 22-25.
15. Devraj-Kizuk R, Chui OHK, Prochownik EV, Carter CJ, Ofosu FA, Blajchman MA. Antithrombin III-Hamilton: a gene with a point mutation (guanine to adenine) in codon 382 causing impaired serine protease reactivity. Blood 1988; 72: 1518-23.
16. Eldering E, Verpy E, Roem D, Meo T, Tosi M. COOH-terminal substitutions in the serpin C1 inhibitor that cause loop overinsertion and subsequent multimerization. J Biol Chem 1995; 270: 2579-87.
17. Bruce D, Perry DJ, Borg J-Y, Carrell RW, Wardell MR. Thromoembolic disease due to thermolabile conformational changes of antithrombin Rouen VI (187 Asn→Asp). J Clin Invest 1994; 94: 2265-74.
18. Darby NJ, Creighton TE. Protein structure. Oxford: IRL Press, 1993: 16.
19. Bennett MJ, Schlunegger MP, Eisenberg D. 3D domain swapping: a mechanism for oligomer assembly. Protein Sci 1995; 4: 2455-68.
20. Perutz MF. Mutations make enzyme polymerize. Nature 1997; 385: 773-75.
21. Carrell RW, Stein PE, Fermi G, Wardell MR. Biological implications of a 3Å structure of dimeric antithrombin. Structure 1994; 2: 257-70.
22. Eriksson S, Janciauskiene S, Lannfelt L. α-antichymotrypsin regulates Alzheimer β-amyloid peptide fibril formation. Proc Natl Acad Sci USA 1995;92: 2313-17.
23. Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntingtons' disease chromosomes. Cell 1993; 72: 971-83.
24. Perutz MF. Glutamine repeats and inherited neurodegenerative diseases: molecular aspects. Curr Opinion Struct Biol 1996; 6: 848-58.
25. Games D, Adams D, Alessandri R, et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 1995; 373: 523-27.
26. Oltersdorf T, Fritz LC, Schenk DB, et al. The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin-II. Nature 1989; 341: 144-47.
27. Davis-Salinas J, Van Nostranel WE. Amyloid β-protein aggregation nullifies its pathologic properties in cultured cerebrovascular smooth muscle cells. J Biol Chem 1995; 270: 20887-90.
28. National Institute on Aging/Alzheimer's Association Working Group. Apolipoprotein E genotyping in Alzheimer's disease. Lancet 1996; 347: 1091-95.
29. Blake C, Serpell L. Synchrotron X-ray studies suggest that the core of the transthyretin amyloid is a continuous β-sheet helix. Structure 1996; 4: 989-98.
30. Booth DR, Sunde M, Bellotti V, et al. Instablity, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature 1997; 385: 787-93.
31. Tan SY, Pepys MB. Amyloidosis. Histopathology 1994; 25: 403-14.
32. Turnell WG, Finch JT. Binding of the dye congo red to the amyloid protein pig insulin reveals a novel homology amongst amyloid-forming peptide sequences. J Mol Biol 1992; 227: 1205-23.
33. Abrahamson M, Grubb A. Increased body temperature accelerates aggregation of the Leu-68→Gln mutant cystatin C, the amyloid-forming protein in hereditary cystatin C amyloid angiopathy. Proc Natl Acad Sci USA 1994; 91: 1416-20.
34. Carrell RW, Lehmann H, Hutchison HE. Haemoglobin Köln (β98 Valine→-Methionine): unstable protein causing inclusion-body anaemia. Nature 1966; 210: 915-16.
35. Bunn HF, Forget BG. Hemoglobin: molecular, genetic and clinical aspects. Philadelphia: WB Saunders, 1986: 453-564.
36. Winterbourn CC, Williamson D, Vissers MCM, Carrell RW. Unstable haemoglobin haemolytic crises: contribution of pyrexia and neutrophil oxidants. Br J Haematol 1981; 49: 111-16.
37. Chinprasertuk S, Wanachiwanawin W, Piankijagum A. Effect of pyrexia in the formation of intraethyrocytic inclusion bodies and vacuoles in haemolytic crisis of haemoglobin H disease. Eur J Haematol 1994; 52: 87-91.
38. El-Radhi AS. Hyperpyrexia in paediatric intensive care. Br J Intensive Care 1996; 6: 305-08.
39. Nelson EAS, Taylor BJ, Weatherall IL. Sleeping position and infant bedding may predispose to hyperthermia and the sudden infant death syndrome. Lancet 1989; i: 199-201.
40. Ponsonby A-L, Dwyer T, Gibbons LE, Jones ME, McCall MJ. Thermal environment and sudden infant death syndrome: case-control study. BMJ 1992; 304: 277-82.